These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35071720)

  • 1. Clinical performance of the Roche Elecsys SARS-CoV-2 antigen fully automated electrochemiluminescence immunoassay.
    Salvagno GL; Pighi L; De Nitto S; Lippi G
    Pract Lab Med; 2022 Mar; 29():e00265. PubMed ID: 35071720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of the fully automated Roche Elecsys SARS-CoV-2 antigen electrochemiluminescence immunoassay: a pooled analysis.
    Lippi G; Henry BM; Adeli K
    Clin Chem Lab Med; 2022 Apr; 60(5):655-661. PubMed ID: 35114742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of SARS-CoV-2 antigen electrochemiluminescence immunoassay to RT-PCR assay for laboratory diagnosis of COVID-19 in Peshawar.
    Iqbal B; Khan M; Shah N; Dawood MM; Jehanzeb V; Shafi M
    Diagnosis (Berl); 2022 Aug; 9(3):364-368. PubMed ID: 34455727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of the Elecsys SARS-CoV-2 antigen assay in the clinical routine of a tertiary care hospital: Preliminary results from a single-center evaluation.
    Mueller T; Kompatscher J; La Guardia M
    J Clin Lab Anal; 2021 Aug; 35(8):e23906. PubMed ID: 34251047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and Validation of the Roche Elecsys SARS-CoV-2 Antigen Electro-Chemiluminescent Immunoassay in a Southeast Asian Region.
    Lau CS; Phua SK; Hoo SP; Jiang B; Aw TC
    Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance evaluation of Elecsys SARS-CoV-2 Antigen immunoassay for diagnostic of COVID-19.
    Montalvo Villalba MC; Sosa Glaria E; Rodriguez Lay LLA; Valdés Ramirez O; Vallina García D; Arencibia Garcia A; Martinez Alfonso J; Menes Llerena DM; Torres Pérez L; Resik Aguirre SR; Guzman Tirado MG
    J Med Virol; 2022 Mar; 94(3):1001-1008. PubMed ID: 34676585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domain.
    Poljak M; Oštrbenk Valenčak A; Štamol T; Seme K
    J Clin Virol; 2021 Apr; 137():104784. PubMed ID: 33711693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of ECLIA antigen detection tests as screening methods for COVID-19 in comparison with molecular analysis.
    Kolesova O; Tomassetti F; Cerini P; Finucci D; Turchetti G; Capogreco F; Bernardini S; Calugi G; Pieri M
    Ir J Med Sci; 2022 Oct; 191(5):2213-2217. PubMed ID: 34850319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay.
    Pighi L; Henry BM; De Nitto S; Gianfilippi G; Salvagno GL; Plebani M; Lippi G
    Clin Chem Lab Med; 2023 Jul; 61(8):1506-1510. PubMed ID: 36883744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between viral load and positivization time of a SARS-CoV-2 rapid antigen test in routine nasopharyngeal specimens.
    Salvagno GL; Henry BM; de NS; Pighi L; Lippi G
    J Med Biochem; 2022 Oct; 41(4):513-517. PubMed ID: 36381068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay.
    Kittel M; Findeisen P; Muth MC; Thiaucourt M; Gerhards C; Neumaier M; Haselmann V
    Int J Infect Dis; 2021 Apr; 105():632-638. PubMed ID: 33578017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicentre Performance Evaluation of the Elecsys Anti-SARS-CoV-2 Immunoassay as an Aid in Determining Previous Exposure to SARS-CoV-2.
    Riester E; Majchrzak M; Mühlbacher A; Tinguely C; Findeisen P; Hegel JK; Laimighofer M; Rank CM; Schönfeld K; Langen F; Laengin T; Niederhauser C
    Infect Dis Ther; 2021 Dec; 10(4):2381-2397. PubMed ID: 34368915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical and Clinical Evaluation of the Automated Elecsys Anti-SARS-CoV-2 Antibody Assay on the Roche cobas e602 Analyzer.
    Chan CW; Parker K; Tesic V; Baldwin A; Tang NY; van Wijk XMR; Yeo KJ
    Am J Clin Pathol; 2020 Oct; 154(5):620-626. PubMed ID: 32814955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.
    Chiereghin A; Zagari RM; Galli S; Moroni A; Gabrielli L; Venturoli S; Bon I; Rossini G; Saracino IM; Pavoni M; Lafratta S; Deni A; Felici S; Borghi M; Guerra L; Raumer L; Lodi V; Viale P; Attard L; Lazzarotto T;
    Front Public Health; 2020; 8():620222. PubMed ID: 33681115
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the Elecsys® Anti-SARS-CoV-2 immunoassay with the EDI™ enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma.
    Egger M; Bundschuh C; Wiesinger K; Gabriel C; Clodi M; Mueller T; Dieplinger B
    Clin Chim Acta; 2020 Oct; 509():18-21. PubMed ID: 32485155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical assessment of the Roche SARS-CoV-2 rapid antigen test.
    Salvagno GL; Gianfilippi G; Bragantini D; Henry BM; Lippi G
    Diagnosis (Berl); 2021 Aug; 8(3):322-326. PubMed ID: 33554511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit.
    Salvagno GL; Gianfilippi G; Pighi L; De Nitto S; Henry BM; Lippi G
    Adv Lab Med; 2021 Aug; 2(3):409-416. PubMed ID: 37362410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Assessment of the DiaSorin LIAISON SARS-CoV-2 Ag Chemiluminescence Immunoassay.
    Salvagno GL; Gianfilippi G; Fiorio G; Pighi L; De Nitto S; Henry BM; Lippi G
    EJIFCC; 2021 Jun; 32(2):216-223. PubMed ID: 34421491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical performance of Fujirebio Lumipulse G SARSCoV- 2 Ag chemiluminescent immunoassay.
    Salvagno GL; Henry BM; De Nitto S; Pighi L; Lippi G
    New Microbiol; 2022 Dec; 45(4):353-354. PubMed ID: 36538301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of a Visually-Read Rapid Antigen Test Kit (SGA V-Chek) for Detection of SARS-CoV-2 Virus].
    Kipritci Z; Keskin AÜ; Çıragil P; Topkaya AE
    Mikrobiyol Bul; 2021 Jul; 55(3):461-464. PubMed ID: 34416811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.